A Study Comparing Duloxetine and Placebo in the Treatment of Fibromyalgia
Status:
Completed
Trial end date:
2009-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to confirm the efficacy and safety of duloxetine 60-120 mg once
daily in comparison to placebo on symptom improvement in patients meeting criteria for
fibromyalgia aged 18 and older. Patients will be randomized to duloxetine or placebo,
however, all patients will receive duloxetine at some point in the study.